ACRV Acrivon Therapeutics, Inc.

NASDAQ

$1.64

Acrivon Therapeutics, Inc. (ACRV) Earnings News

Earnings press releases, previews and reviews for Acrivon Therapeutics, Inc. (ACRV), newest first.

Wednesday August 12, 2026 4:05 PM ET

Acrivon Reports Second Quarter 2026 Financial Results and Highlights Upcoming 2026 Clinical Data Catalysts

Wednesday May 13, 2026 4:10 PM ET

Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts